Maximizing the Benefit of Life-Saving Treatments for Pompe Disease, Spinal Muscular Atrophy, and Duchenne Muscular Dystrophy Through Newborn Screening-Reference-Cited by-同舟云学术

Maximizing the Benefit of Life-Saving Treatments for Pompe Disease, Spinal Muscular Atrophy, and Duchenne Muscular Dystrophy Through Newborn Screening

Published:2019-08-01 Issue:8 Volume:76 Page:978
ISSN:2168-6149
Container-title:JAMA Neurology
language:en
Short-container-title:JAMA Neurol

Author:

Baker Mei¹,Griggs Robert²,Byrne Barry³,Connolly Anne M.⁴,Finkel Richard⁵,Grajkowska Lucja⁶,Haidet-Phillips Amanda⁶,Hagerty Laura⁶,Ostrander Robert⁷,Orlando Lianna⁶,Swoboda Kathryn⁸,Watson Michael⁹,Howell R. Rodney¹⁰

Affiliation:

1. University of Wisconsin School of Medicine, Madison

2. University of Rochester School of Medicine, Rochester, New York

3. University of Florida, Gainesville

4. Washington University School of Medicine in St Louis, St Louis, Missouri

5. Nemours Children’s Hospital, Orlando, Florida

6. Muscular Dystrophy Association, New York, New York

7. State University of New York Upstate Medical University, Rushville

8. Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts

9. American College of Medical Genetics and Genomics, Bethesda, Maryland

10. University of Miami Miller School of Medicine, Miami, Florida

Publisher